CA967964A - 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine - Google Patents

2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine

Info

Publication number
CA967964A
CA967964A CA139,774A CA139774A CA967964A CA 967964 A CA967964 A CA 967964A CA 139774 A CA139774 A CA 139774A CA 967964 A CA967964 A CA 967964A
Authority
CA
Canada
Prior art keywords
triethoxybenzyl
diamino
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA139,774A
Other languages
English (en)
Other versions
CA139774S (en
Inventor
Barbara Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to CA180,135A priority Critical patent/CA967963A/en
Application granted granted Critical
Publication of CA967964A publication Critical patent/CA967964A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA139,774A 1971-04-16 1972-04-14 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine Expired CA967964A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA180,135A CA967963A (en) 1971-04-16 1973-08-31 Intermediates in the preparation of 2,4-diamino-5-benzylpyrimidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB963971A GB1407971A (en) 1971-04-16 1971-04-16 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor

Publications (1)

Publication Number Publication Date
CA967964A true CA967964A (en) 1975-05-20

Family

ID=9875880

Family Applications (1)

Application Number Title Priority Date Filing Date
CA139,774A Expired CA967964A (en) 1971-04-16 1972-04-14 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine

Country Status (13)

Country Link
JP (3) JPS5320511B1 (en:Method)
AU (1) AU468447B2 (en:Method)
BE (1) BE782153A (en:Method)
CA (1) CA967964A (en:Method)
CH (1) CH565160A5 (en:Method)
CS (1) CS181221B2 (en:Method)
DE (1) DE2218220A1 (en:Method)
DK (1) DK131466B (en:Method)
FR (1) FR2133752B1 (en:Method)
GB (1) GB1407971A (en:Method)
IL (3) IL47921A (en:Method)
NL (1) NL7205043A (en:Method)
SE (1) SE391180B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
FR2502152A1 (fr) * 1981-03-20 1982-09-24 Panmedica Laboratoires Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (fr) * 1953-03-11 1955-03-30 Wellcome Found Dérivés de pyrimidine et leur fabrication
FR1459417A (fr) * 1964-11-12 1966-04-29 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
FR1518635A (fr) * 1965-07-08 1968-03-29 Wellcome Found Procédé de préparation de dérivés de la pyrimidine
GB1261455A (en) * 1969-03-06 1972-01-26 Burroughs Wellcome Co Improvements in or relating to substituted acrylonitriles

Also Published As

Publication number Publication date
BE782153A (fr) 1972-10-16
AU4117472A (en) 1973-10-18
IL47921A0 (en) 1975-11-25
AU468447B2 (en) 1976-01-15
JPS5430189A (en) 1979-03-06
FR2133752A1 (en:Method) 1972-12-01
GB1407971A (en) 1975-10-01
IL39218A (en) 1976-10-31
NL7205043A (en:Method) 1972-10-18
IL39218A0 (en) 1972-06-28
SE391180B (sv) 1977-02-07
DK131466B (da) 1975-07-21
JPS5422994B2 (en:Method) 1979-08-10
FR2133752B1 (en:Method) 1975-04-25
IL47921A (en) 1976-10-31
DE2218220A1 (de) 1972-11-02
CH565160A5 (en:Method) 1975-08-15
CS181221B2 (en) 1978-03-31
JPS5320511B1 (en:Method) 1978-06-27
DK131466C (en:Method) 1975-12-08
JPS53111083A (en) 1978-09-28

Similar Documents

Publication Publication Date Title
AU466496B2 (en) Pyrimidine derivatives
CA965104A (en) 3,4,5-trialkylcyclohexanols
CA989839A (en) 5-(3-iodopropargyloxy) pyrimidine
AU460810B2 (en) Pyrimidine fungicides
CA1010863A (en) 2-substitutedthio-s-triazolo(1,5a)pyrimidines
ZA727274B (en) Pyride(2,3-d)pyrimidines
AU462099B2 (en) Isopropylamino pyrimidine derivatives
AU3212671A (en) Substituted uracils
AU4190272A (en) 2,5-bis-substituted pyrimidines
AU465145B2 (en) 2, 4-diamino-5-benzylpyrimidines
AU4117472A (en) 2, 4-diamino-5-benzyl-pyrimidines
PH11029A (en) 2,4-diamino-5-(3-alkoxy-4,5-methylene-dioxybenzyl)pyrimidine
CA887650A (en) 2,7-diamino-6-arylpyrido(2,3) pyrimidine derivatives
CA1026338A (en) 2,4-diamino pyrimidines
CA835990A (en) 1,2-dihydro-1-hydroxy-2-carboxyacyl-imino-6-lower-alkyl pyrimidine derivatives
CA989833A (en) 8-d-ribitylpyrido (2,3-d)pyrimidines
CA837636A (en) 1,3-diazacyclo-2,4-butanediones
CA867383A (en) 2,4,5,6-tetrachloropyrimidine
PH12078A (en) 2,4-diamino-5-(2or4-hydroxybenzyl)pyrimidines
AU481813B2 (en) 2-SUBSTITUTED THIO-s-TRIAZOLO (1,5a)PYRIMIDINES
AU3151271A (en) Substituted 1, 3-indandiols
AU457397B2 (en) AMINOALKYLAMINOTHIENO [3, 2-d J PYRIMIDINES
CA862115A (en) Pyrimidine derivatives
CA883833A (en) Pyrimidine derivatives
CA845721A (en) Chloropyrimidines